Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.
(2026 Jun 22)
Nat Genet
Rossi F, Sportelli L, Kikidis GC, Grassi G, Di Camillo F, Bertolino A, Blasi G, Borcuk CJ, Fusco D, Hyde TM, Kleinman JE, Marnetto D, Pellegrini S, Rampino A, Vitiello B, Ripke S, Braun A, Kraft J, Belangero SI, Menezes PR, Arango C, Walters JTR, O'Donovan MC, Owen MJ, Braff D, Corvin A, Morris DW, Domenici E, van Os J, Atbaşoğlu E, Saka MC, Di Forti M, Baune BT, Pato CN, McQuillin A, Golimbet V, Kondratyev N, Escott-Price V, Gareeva A, Khusnutdinova E, Cervilla JA, Rivera M, Campion D, Laurent-Levinson C, Serretti A, Andreassen OA, St Clair D, Lencz T, Malhotra AK, McCarthy NS, Mowry BJ, Rujescu D, Giegling I, Hartmann AM, Konte B, Nöthen MM, Rietschel M, Kirov G, Sullivan PF, Petryshen TL, Werge T, McIntosh AM, Esko T, Jönsson EG, Ehrenreich H, Riley BP, Levinson DF, Buxbaum JD, Bramon E, Hultman CM, Ophoff RA, Adolfsson R, Stahl EA, Guloksuz S, Rutten BPF, Del-Ben CM, Thibaut F, Weinberger DR, Pergola G

A qualitative exploration of orthodontists' perceptions of social media marketing of orthodontics.
(2026 Jun 22)
Br Dent J
Dhadwal A, Hurst D, Fleming PS

Re-evaluating response rates, time to reorientation and inadequate seizure duration in magnetic seizure therapy for schizophrenia and major depression.
(2026 Jun 22)
Mol Psychiatry
Jelovac A, Braithwaite R

Corrigendum to "Pulmonary Delivery of siRNA Lipoplexes and Lipid Nanoparticles using a Vibrating Mesh Nebuliser" [European Journal of Pharmaceutical Sciences 107386 216(2026)].
(2026 Jun 22)
Eur J Pharm Sci
Neary MT, Mulder LM, Leime CO, MacLoughlin R, Grassiri B, Baranowski Ł, Kowalski PS, Crean AM, Ryan KB

Oral oxycodone versus sublingual buprenorphine for postoperative pain control after pelvic exenteration (PROSPER): a pilot, registry-embedded, multi-centre, double-blind, placebo-controlled, randomised controlled trial.
(2026 Jun 22)
BMJ Open 16(6): e117594
Johnstone C, Koh C, Mathieson S, Steffens D, White K, Gray P, Harris C, Heriot A, Kramer K, Law CK, Lin CC, Liu X, Machado G, McLachlan A, Penm J, Riedel B, Sammour T, Sanders R, Solomon M, Whitehead L, Winter D, Young J, Patanwala A

Show complete publication list

In the News